198 related articles for article (PubMed ID: 37903757)
1. Homodimer-mediated phosphorylation of C/EBPα-p42 S16 modulates acute myeloid leukaemia differentiation through liquid-liquid phase separation.
Wang D; Sun T; Xia Y; Zhao Z; Sheng X; Li S; Ma Y; Li M; Su X; Zhang F; Li P; Ma D; Ye J; Lu F; Ji C
Nat Commun; 2023 Oct; 14(1):6907. PubMed ID: 37903757
[TBL] [Abstract][Full Text] [Related]
2. C/EBPα-p30 confers AML cell susceptibility to the terminal unfolded protein response and resistance to Venetoclax by activating DDIT3 transcription.
Du M; Wang M; Liu M; Fu S; Lin Y; Huo Y; Yu J; Yu X; Wang C; Xiao H; Wang L
J Exp Clin Cancer Res; 2024 Mar; 43(1):79. PubMed ID: 38475919
[TBL] [Abstract][Full Text] [Related]
3. The presence of C/EBPα and its degradation are both required for TRIB2-mediated leukaemia.
O'Connor C; Lohan F; Campos J; Ohlsson E; Salomè M; Forde C; Artschwager R; Liskamp RM; Cahill MR; Kiely PA; Porse B; Keeshan K
Oncogene; 2016 Oct; 35(40):5272-5281. PubMed ID: 26996668
[TBL] [Abstract][Full Text] [Related]
4. Restoration of CCAAT enhancer binding protein α P42 induces myeloid differentiation and overcomes all-trans retinoic acid resistance in human acute promyelocytic leukemia NB4-R1 cells.
Wang L; Xiao H; Zhang X; Liao W; Fu S; Huang H
Int J Oncol; 2015 Nov; 47(5):1685-95. PubMed ID: 26397153
[TBL] [Abstract][Full Text] [Related]
5. E6AP, an E3 ubiquitin ligase negatively regulates granulopoiesis by targeting transcription factor C/EBPα for ubiquitin-mediated proteasome degradation.
Pal P; Lochab S; Kanaujiya JK; Kapoor I; Sanyal S; Behre G; Trivedi AK
Cell Death Dis; 2013 Apr; 4(4):e590. PubMed ID: 23598402
[TBL] [Abstract][Full Text] [Related]
6.
Liu M; Du M; Yu J; Qian Z; Gao Y; Pan W; Zhao X; Wang M; Li H; Zheng J; Huang Q; Wang LM; Xiao H
Oncoimmunology; 2022; 11(1):2016158. PubMed ID: 35003895
[TBL] [Abstract][Full Text] [Related]
7. Transcription factor C/EBPα-induced microRNA-30c inactivates Notch1 during granulopoiesis and is downregulated in acute myeloid leukemia.
Katzerke C; Madan V; Gerloff D; Bräuer-Hartmann D; Hartmann JU; Wurm AA; Müller-Tidow C; Schnittger S; Tenen DG; Niederwieser D; Behre G
Blood; 2013 Oct; 122(14):2433-42. PubMed ID: 23974200
[TBL] [Abstract][Full Text] [Related]
8. [Roles of CCAAT enhancer binding protein α in acute myeloblastic leukemia].
Shi T; Ye X
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2018 May; 47(5):552-557. PubMed ID: 30693699
[TBL] [Abstract][Full Text] [Related]
9. Functional inhibition of MEF2 by C/EBP is a possible mechanism of leukemia development by CEBP-IGH fusion gene.
Odaira K; Yasuda T; Okada K; Shimooka T; Kojima Y; Noura M; Tamura S; Kurahashi S; Iwamoto E; Sanada M; Matsumura I; Miyazaki Y; Kojima T; Kiyoi H; Tsuzuki S; Hayakawa F
Cancer Sci; 2023 Mar; 114(3):781-792. PubMed ID: 36341510
[TBL] [Abstract][Full Text] [Related]
10. Ring finger protein 138 inhibits transcription factor C/EBPα protein turnover leading to differentiation arrest in acute myeloid leukemia.
Singh AK; Upadhyay V; Sethi A; Chowdhury S; Mishra S; Verma SP; Bhatt MLB; Trivedi AK
Biochem J; 2024 May; 481(10):653-666. PubMed ID: 38666590
[TBL] [Abstract][Full Text] [Related]
11. E3 ligase SCF
Thacker G; Mishra M; Sharma A; Singh AK; Sanyal S; Trivedi AK
Life Sci; 2020 Sep; 257():118041. PubMed ID: 32622945
[TBL] [Abstract][Full Text] [Related]
12. Elevated PIN1 expression by C/EBPalpha-p30 blocks C/EBPalpha-induced granulocytic differentiation through c-Jun in AML.
Pulikkan JA; Dengler V; Peer Zada AA; Kawasaki A; Geletu M; Pasalic Z; Bohlander SK; Ryo A; Tenen DG; Behre G
Leukemia; 2010 May; 24(5):914-23. PubMed ID: 20376080
[TBL] [Abstract][Full Text] [Related]
13. Establishment of the acute myeloid leukemia cell line Kasumi-6 from a patient with a dominant-negative mutation in the DNA-binding region of the C/EBPalpha gene.
Asou H; Gombart AF; Takeuchi S; Tanaka H; Tanioka M; Matsui H; Kimura A; Inaba T; Koeffler HP
Genes Chromosomes Cancer; 2003 Feb; 36(2):167-74. PubMed ID: 12508245
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of serine 21 modulates the proliferation inhibitory more than the differentiation inducing effects of C/EBPα in K562 cells.
Fragliasso V; Chiodo Y; Ferrari-Amorotti G; Soliera AR; Manzotti G; Cattelani S; Candini O; Grisendi G; Vergalli J; Mariani SA; Guerzoni C; Calabretta B
J Cell Biochem; 2012 May; 113(5):1704-13. PubMed ID: 22212957
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the C/EBPα signaling pathway in acute myeloid leukemia (Review).
Song G; Wang L; Bi K; Jiang G
Oncol Rep; 2015 May; 33(5):2099-106. PubMed ID: 25760953
[TBL] [Abstract][Full Text] [Related]
16. C/EBPα in normal and malignant myelopoiesis.
Friedman AD
Int J Hematol; 2015 Apr; 101(4):330-41. PubMed ID: 25753223
[TBL] [Abstract][Full Text] [Related]
17. C/EBPα-p30 protein induces expression of the oncogenic long non-coding RNA UCA1 in acute myeloid leukemia.
Hughes JM; Legnini I; Salvatori B; Masciarelli S; Marchioni M; Fazi F; Morlando M; Bozzoni I; Fatica A
Oncotarget; 2015 Jul; 6(21):18534-44. PubMed ID: 26053097
[TBL] [Abstract][Full Text] [Related]
18. A C/ebpα isoform specific differentiation program in immortalized myelocytes.
Garcia-Cuellar MP; Akan S; Slany RK
Leukemia; 2023 Sep; 37(9):1850-1859. PubMed ID: 37532789
[TBL] [Abstract][Full Text] [Related]
19. Acetylation of C/EBPα inhibits its granulopoietic function.
Bararia D; Kwok HS; Welner RS; Numata A; Sárosi MB; Yang H; Wee S; Tschuri S; Ray D; Weigert O; Levantini E; Ebralidze AK; Gunaratne J; Tenen DG
Nat Commun; 2016 Mar; 7():10968. PubMed ID: 27005833
[TBL] [Abstract][Full Text] [Related]
20. CDK2-instigates C/EBPα degradation through SKP2 in Acute myeloid leukemia.
Thacker G; Mishra M; Sharma A; Singh AK; Sanyal S; Trivedi AK
Med Oncol; 2021 May; 38(6):69. PubMed ID: 34002296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
